CoChat

Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice

Zakariassen, Hannah Louise, John, Linu Mary, Lykkesfeldt, Jens, Raun, Kirsten, Glendorf, Tine, Schaffer, Lauge, Lundh, Sofia, Secher, Anna, Lutz, Thomas Alexander, Le Foll, Christelle · 2020 · Neuropharmacology
Cited by 33

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

The amylin receptor (AMY) and calcitonin receptor (CTR) agonists induce acute suppression of food intake in rodents by binding to receptors in the area postrema (AP) and potentially by targeting arcuate (ARC) neurons directly. Salmon calcitonin (sCT) induces more potent, longer lasting anorectic effects compared to amylin. We thus aimed to investigate whether AMY/CTR agonists target key neuronal populations in the ARC, and whether differing brain distribution patterns could mediate the observed differences in efficacy with sCT and amylin treatment. Brains were examined by whole brain 3D imaging and confocal microscopy following subcutaneous administration of fluorescently labelled peptides to male and female mice. We found that sCT, but not amylin, internalizes into a subset of ARC NPY neurons, along with an unknown subset of ARC, AP and dorsal vagal motor nucleus cells. ARC POMC neurons were not targeted. Furthermore, amylin and sCT displayed similar distribution patterns when binding to receptors in the AP, the organum vasculosum of the lamina terminalis (OVLT) and the ARC. Amylin was distributed within the median eminence with only specs of sCT being present in this region, however amylin was only detectable 10 min after injection while sCT displayed a residence time of up to 2 h post injection. We conclude that AMY/CTR agonists bind to receptors in a subset of ARC NPY neurons and in circumventricular organs. Furthermore, the more sustained and greater anorectic efficacy of sCT compared to rat amylin is not attributable to differences in brain distribution patterns but may more likely be explained by greater potency at both CTR and AMY3.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuropharm.2020.107987

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 33

Metadata

Authors
Zakariassen, H. L., John, L. M., Lykkesfeldt, J., Raun, K., Glendorf, T., Schaffer, L., Lundh, S., Secher, A., Lutz, T. A., & Le Foll, C.
Venue
Neuropharmacology
Publisher
Elsevier BV
Published
2020-05
Volume
167
Pages
107987
ISSN
0028-3908 (ISSN-L)
OpenAlex
W3004880305
Cited by
33
References
9
FWCI
2.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice. https://app.cochat.ai/papers/10.1016/j.neuropharm.2020.107987
The paper
Zakariassen, H. L., John, L. M., Lykkesfeldt, J., Raun, K., Glendorf, T., Schaffer, L., Lundh, S., Secher, A., Lutz, T. A., & Le Foll, C. (2020). Salmon calcitonin distributes into the arcuate nucleus to a subset of NPY neurons in mice. Neuropharmacology. https://doi.org/10.1016/j.neuropharm.2020.107987

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.